Trending
October 7, 2024 Actylis Acquires Pharm-RxOctober 4, 2024 Novita Pharmaceuticals Appoints Stewart Campbell as Chief Executive OfficerOctober 2, 2024 Triveni Bio Raises $115 Million in Series BOctober 1, 2024 Halda Therapeutics Appoints Christian Schade as CEOOctober 1, 2024 Luxa Biotechnology Appoints Keith E. Dionne, Ph.D., as Chief Executive Officer
Featured
October 7, 2024
Actylis Acquires Pharm-Rx
PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--Actylis, a provider of choice for life sciences and advanced technology... Read more »
October 4, 2024
Novita Pharmaceuticals Appoints Stewart Campbell as Chief Executive Officer
Novita Pharmaceuticals, Inc., a privately held, clinical-stage pharmaceutical company dedicated to developing... Read more »
October 2, 2024
Triveni Bio Raises $115 Million in Series B
Triveni Bio Inc., a biotech company advancing novel antibody treatments for I&I disorders, today announced a $115... Read more »
October 2, 2024
VNACJ Community Health Center Secures HRSA Grant to Expand Mental Health and Substance Use Disorder Services in Monmouth County
October 1, 2024
Merck Completes Acquisition of Investigational B-Cell Depletion Therapy, CN201, from Curon Biopharmaceutical
